| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 161.56B | 150.91B | 134.27B | 130.13B | 118.38B | 121.71B |
| Gross Profit | 83.08B | 77.31B | 69.46B | 67.18B | 59.09B | 55.02B |
| EBITDA | 10.84B | 9.64B | 9.21B | 8.43B | 3.64B | -4.98B |
| Net Income | 5.92B | 4.28B | 4.88B | 4.34B | 732.00M | -7.20B |
Balance Sheet | ||||||
| Total Assets | 79.16B | 70.55B | 60.42B | 61.18B | 59.70B | 63.62B |
| Cash, Cash Equivalents and Short-Term Investments | 6.27B | 6.67B | 6.49B | 8.56B | 5.59B | 6.60B |
| Total Debt | 8.20B | 1.03B | 202.00M | 2.50B | 7.80B | 15.60B |
| Total Liabilities | 36.50B | 32.73B | 25.39B | 27.48B | 29.63B | 33.77B |
| Stockholders Equity | 42.66B | 37.82B | 35.03B | 33.70B | 30.07B | 29.84B |
Cash Flow | ||||||
| Free Cash Flow | -2.55B | 4.46B | 3.26B | 9.10B | 5.96B | -6.76B |
| Operating Cash Flow | 3.42B | 7.10B | 6.34B | 10.26B | 6.89B | -4.28B |
| Investing Cash Flow | -7.39B | -6.24B | -2.66B | -1.25B | 215.00M | -4.08B |
| Financing Cash Flow | 3.32B | -699.00M | -5.77B | -5.98B | -8.00B | 9.27B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥19.45T | 29.11 | 19.84% | 0.90% | 9.56% | 16.37% | |
72 Outperform | ¥70.47B | 3.05 | ― | 2.73% | 10.48% | -34.38% | |
71 Outperform | ¥122.95B | 24.22 | 5.53% | 6.09% | -1.03% | 4.12% | |
70 Outperform | ¥257.12B | 19.60 | ― | 1.46% | 12.02% | -15.70% | |
68 Neutral | ¥738.53B | 16.45 | 8.48% | 2.02% | ― | ― | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
48 Neutral | ¥27.08B | 13.91 | ― | 4.99% | -7.21% | -5127.88% |